Evidence map›Paper›PMID 40807812›Full record

ArticleSensors (Basel, Switzerland)2025

Incorporating Uncertainty Estimation and Interpretability in Personalized Glucose Prediction Using the Temporal Fusion Transformer.

Antonio J Rodriguez-Almeida, Carmelo Betancort, Ana M Wägner, Gustavo M Callico, Himar Fabelo, On Behalf Of The Warifa Consortium

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonio J Rodriguez-AlmeidaInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, 35017 Las Palmas de Gran Canaria, Spain.ORCID 0000-0001-6358-5745
Carmelo BetancortEndocrinology and Nutrition Department, Complejo Hospitalario Universitario Insular Materno-Infantil, CHUIMI, 35016 Las Palmas de Gran Canaria, Spain.
Ana M WägnerEndocrinology and Nutrition Department, Complejo Hospitalario Universitario Insular Materno-Infantil, CHUIMI, 35016 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-7663-9308
Gustavo M CallicoInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, 35017 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-3784-5504
Himar FabeloInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, 35017 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-9794-490X
On Behalf Of The Warifa Consortium

Funding

Agencia Canaria de Investigación, Innovación y Sociedad de la Información European Social Fund (FSE) (POC 2014-2020, Eje 3 Tema Prioritario 74 (85 %))European Union 01017385
6 · The paper itself

Abstract

More than 14% of the world's population suffered from diabetes mellitus in 2022. This metabolic condition is defined by increased blood glucose concentrations. Among the different types of diabetes, type 1 diabetes, caused by a lack of insulin secretion, is particularly challenging to treat. In this regard, automatic glucose level estimation implements Continuous Glucose Monitoring (CGM) devices, showing positive therapeutic outcomes. AI-based glucose prediction has commonly followed a deterministic approach, usually with a lack of interpretability. Therefore, these AI-based methods do not provide enough information in critical decision-making scenarios, like in the medical field. This work intends to provide accurate, interpretable, and personalized glucose prediction using the Temporal Fusion Transformer (TFT), and also includes an uncertainty estimation. The TFT was trained using two databases, an in-house-collected dataset and the OhioT1DM dataset, commonly used for glucose forecasting benchmarking. For both datasets, the set of input features to train the model was varied to assess their impact on model interpretability and prediction performance. Models were evaluated using common prediction metrics, diabetes-specific metrics, uncertainty estimation, and interpretability of the model, including feature importance and attention. The obtained results showed that TFT outperforms existing methods in terms of RMSE by at least 13% for both datasets.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1AlgorithmsHumansUncertaintyBlood Glucoseartificial intelligencedeep learningexplainable AIglucose predictionmHealthpersonalized medicinetransformers

Identifiers

PMID40807812
PMCPMC12349322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.